Navigation Links
Gastrointestinal Disorders Therapeutics to 2016 - High Unmet Needs Triggering Strong Growth in Crohn's Disease and Irritable Bowel Syndrome Markets Now Available at ReportsandReports
Date:6/28/2010

lobal, Pipeline by Phase (%), 2009 1

Figure 2: Gastrointestinal Disorder Therapeutics Market, Global, Licensing Agreements Split by Phase (%), 1998-2010 2

Figure 3: Gastrointestinal Disorder Therapeutics Market, Global, Revenue ($m), 2001-2016 14

Figure 4: Gastrointestinal Disorder Therapeutics Market, Global, Annual Cost of Treatment, 2001-2016 15

Figure 5: Gastrointestinal Disorder Therapeutics Market, Global, Diseased Population, 2001-2016 16

Figure 6: Gastrointestinal Disorder Therapeutics Market, Global, Treatment Seeking Population, 2001-2016 17

Figure 7: Gastrointestinal Disorder Therapeutics Market, Global, Diagnosis Population, 2001-2016 18

Figure 8: Gastrointestinal Disorder Therapeutics Market, Global, Prescription Population, 2001-2016 19

Figure 9: Gastrointestinal Disorder Therapeutics Market, Global, Usage Patterns, 2001-2016 20

Figure 10: Gastrointestinal Disorder Therapeutics Market, Global, Geographical Distribution of Revenues ($bn), 2001-2016 21

Figure 11: Gastrointestinal Disorder Therapeutics Market, The US, Revenue ($m), 2001-2016 22

Figure 12: Gastrointestinal Disorder Therapeutics Market, The US, Annual Cost of Treatment, 2001-2016 23

Figure 13: Gastrointestinal Disorder Therapeutics Market, The US, Diseased Population, 2001-2016 24

Figure 14: Gastrointestinal Disorder Therapeutics Market, The US, Treatment Seeking Population, 2001-2016 25

Figure 15: Gastrointestinal Disorder Therapeutics Market, The US, Diagnosis Population, 2001-201
'/>"/>

SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related biology technology :

1. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
2. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
3. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
4. DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD
5. Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
6. New Study Showed the Impact of Gastrointestinal Disorders in Patients With Parkinsons Disease
7. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
8. TAP Pharmaceutical Products Inc. Files New Drug Application for TAK-390MR in Patients with Acid-Related Disorders
9. Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders
10. SleepQuest Raises Awareness of Sleep Disorders
11. S*BIO Receives Orphan Drug Designation for JAK2 Inhibitor SB1518 for the Treatment of Myeloproliferative Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... (PRWEB) June 18, 2013 (PRWEB) June 18, 2013 ... time and attendance system in North America, has ... shares employee data and payroll records between ExakTime’s ... Plus automates ExakTime software setup and keeps ... imports employee data from a business’ current payroll ...
(Date:6/18/2013)... Phoenix, AZ (PRWEB) June 18, 2013 ... the 2013 Innovation Challenge Winner out of hundreds of ... in its spring Arizona Innovation Challenge . The ... the country for a technology commercialization challenge, granting a ... world’s most promising technology ventures. Nasseo’s state of the ...
(Date:6/18/2013)... 2013  AMRI (NASDAQ: AMRI ) ... , site has received approval to expand ... to handle Schedule 2 and 2N controlled substances. ... Burlington,s physical security and quality ... (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) With ...
(Date:6/18/2013)... Research and Markets ... of the report " DNA Sequencing - ... offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... human genome variations, development of sequencing technologies, ... sequencers are described as well as companies ...
Breaking Biology Technology:ExakTime Introduces AccountLinx Plus 2Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2
... has been so much media attention focused on the ... finally shedding some light on the issue. Whatever the ... America to cheaper labor. The effects of this are ... It doesnt matter what you are making, whether you ...
... Among the reasons North Carolina Sen. John Edwards polled ... thinks the North American Free Trade Agreement has been a ... voters who are eager to blame the states economic troubles ... really not that short-sighted. Free trade is a part of ...
... Wis.- Gundersen Lutheran Health System is reducing surgery delays ... management of its surgical instruments and trays by using ... Minn.- based Lawson Software. , ,Gundersen Lutheran operates ... of the nation's largest group medical practices, community clinics, ...
Cached Biology Technology:Offshore outsourcing affects American workers 2Offshore outsourcing affects American workers 3A Vote Against Free Trade is a Vote Against Wisconsins Long-Term Interests 2Gunderson Lutheran Implements Instrument Management Systems 2
(Date:6/17/2013)... and algae, is a common component of sugar-free gum ... medical field it,s approved by the FDA as ... during surgery as a substance that opens the blood/brain ... Now Profs. Ehud Gazit and Daniel Segal of Tel ... the Sagol School of Neuroscience, along with their colleague ...
(Date:6/17/2013)... The AGA Research Foundation and Horizon Pharma further establish ... with the 2013 AGA-Horizon Pharma Fellow Abstract Prizes and ... its third year, this competition continues to grow in ... careers in basic and clinical research," said Nicholas F. ... "We are extremely proud of all that these fellows ...
(Date:6/17/2013)... Amphibian populations are declining worldwide and a major cause ... bullfrogs, but a two-year study shows they can also ... are a tolerant carrier host that just spreads the ... in controlled experimental conditions, they found at least one ... called Bd or a chytrid fungus, can be fatal ...
Breaking Biology News(10 mins):Artificial sweetener a potential treatment for Parkinson's disease 2Horizon Pharma Abstract Prizes recognize promising fellows and students 2Bullfrogs may help spread deadly amphibian fungus, but also die from it 2
... more foreign children in the classroom, and many of them ... A study by the University of Gerona has assessed the ... that they take at least six years to acquire the ... system that has proven successful in other countries as a ...
... at the University of Leeds have come a step closer ... Their findings, published in the International Journal of ... developed to tackle other cancers should be considered as a ... as tamoxifen, that target a protein responsible for tumour growth, ...
... at The University of Texas Health Science Center at ... study the spread of E. coli , a ... Jennifer Juarez received fellowships from the American Society for ... The ASM fellowship supports professional development and the NIH ...
Cached Biology News:Foreign children take at least 6 years to learn the language used in school 2Foreign children take at least 6 years to learn the language used in school 3Another step toward resisting breast cancer 2UTHealth student earns fellowships to research major source of bacterial infections 2
... Ultrasonic Nebulizers are available in two product models ... these two models is that the 6000AT+ includes ... a drier aerosol for improved detection limits and ... for a range of elements by 10-40 times. ...
...
... For potent inhibition of RNase A-type ribonucleases ... protein of nonhuman origin that binds noncovalently ... RNase A, B, and C). It does ... U1, U2, or CL3. QIAGEN RNase Inhibitor ...
...
Biology Products: